Canada markets closed

AnaptysBio, Inc. (ANAB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
19.87+0.04 (+0.20%)
At close: 04:00PM EDT
19.88 +0.01 (+0.05%)
After hours: 04:25PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
17,157
17,157
10,287
63,175
75,000
Operating Expenses
Research Development
132,283
132,283
88,798
98,496
80,025
Selling General and Administrative
41,946
41,946
36,643
21,493
18,854
Total Operating Expenses
174,229
174,229
125,441
119,989
98,879
Operating Income or Loss
-157,072
-157,072
-115,154
-56,814
-23,879
Interest Expense
18,083
18,083
21,108
1,450
0
Total Other Income/Expenses Net
-7,341
-7,341
12
37
-11
Income Before Tax
-163,623
-163,623
-128,700
-57,796
-19,931
Income Tax Expense
-4
-4
24
0
0
Income from Continuing Operations
-163,619
-163,619
-128,724
-57,796
-19,931
Net Income
-163,619
-163,619
-128,724
-57,796
-19,931
Net Income available to common shareholders
-163,619
-163,619
-128,724
-57,796
-19,931
Basic EPS
-3.00
-6.08
-4.57
-2.11
-0.73
Diluted EPS
-3.00
-6.08
-4.57
-2.11
-0.73
Basic Average Shares
26,242
26,924
28,165
27,431
27,302
Diluted Average Shares
26,242
26,924
28,165
27,431
27,302